267 related articles for article (PubMed ID: 18515453)
1. Effect of distigmine bromide on the central cholinergic system.
Nakayama K; Katsu H; Kitazumi K
J Psychopharmacol; 2009 Mar; 23(2):190-3. PubMed ID: 18515453
[TBL] [Abstract][Full Text] [Related]
2. N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine.
Cerbai F; Giovannini MG; Melani C; Enz A; Pepeu G
Eur J Pharmacol; 2007 Oct; 572(2-3):142-50. PubMed ID: 17643410
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic analysis of acetylcholinesterase inhibition by distigmine bromide in rats.
Ito Y; Harada T; Fushimi K; Kagawa Y; Oka H; Nakazawa H; Homma R; Kato Y; Yamada S
Drug Metab Pharmacokinet; 2010; 25(3):254-61. PubMed ID: 20610884
[TBL] [Abstract][Full Text] [Related]
4. Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat.
Tang XC; De Sarno P; Sugaya K; Giacobini E
J Neurosci Res; 1989 Oct; 24(2):276-85. PubMed ID: 2585551
[TBL] [Abstract][Full Text] [Related]
5. Changes in cholinesterase system in different brain areas during the development of behavioral tolerance to monocrotophos toxicity in male albino rats.
Swamy KV; Ravikumar R; Mohan PM
Biochem Int; 1992 Aug; 27(4):661-9. PubMed ID: 1417899
[TBL] [Abstract][Full Text] [Related]
6. Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors.
Gobert A; Di Cara B; Cistarelli L; Millan MJ
J Pharmacol Exp Ther; 2003 Apr; 305(1):338-46. PubMed ID: 12649387
[TBL] [Abstract][Full Text] [Related]
7. Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity.
Hartmann J; Kiewert C; Duysen EG; Lockridge O; Greig NH; Klein J
J Neurochem; 2007 Mar; 100(5):1421-9. PubMed ID: 17212694
[TBL] [Abstract][Full Text] [Related]
8. Effect of galantamine on acetylcholinesterase and butyrylcholinesterase activities in the presence of L-carnitine in rat selected brain and peripheral tissues.
Svoboda Z; Kvetina J; Kunesová G; Herink J; Bajgar J; Bartosová L; Zivný P; Palicka V
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():183-6. PubMed ID: 17159811
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.
Liang YQ; Tang XC
Acta Pharmacol Sin; 2006 Sep; 27(9):1127-36. PubMed ID: 16923332
[TBL] [Abstract][Full Text] [Related]
10. Gender-related differences in circadian rhythm of rat plasma acetyl- and butyrylcholinesterase: effects of sex hormone withdrawal.
Alves-Amaral G; Pires-Oliveira M; Andrade-Lopes AL; Chiavegatti T; Godinho RO
Chem Biol Interact; 2010 Jun; 186(1):9-15. PubMed ID: 20399201
[TBL] [Abstract][Full Text] [Related]
11. The impact of acetylcholinesterase inhibitors on the extracellular acetylcholine concentrations in the adult rat brain: a meta-analysis.
Noori HR; Fliegel S; Brand I; Spanagel R
Synapse; 2012 Oct; 66(10):893-901. PubMed ID: 22733599
[TBL] [Abstract][Full Text] [Related]
12. Developmental lead neurotoxicity: alterations in brain cholinergic system.
Reddy GR; Devi BC; Chetty CS
Neurotoxicology; 2007 Mar; 28(2):402-7. PubMed ID: 16678265
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
Huang L; Luo Z; He F; Lu J; Li X
Bioorg Med Chem; 2010 Jun; 18(12):4475-84. PubMed ID: 20471843
[TBL] [Abstract][Full Text] [Related]
14. Effects of T-82, a new quinoline derivative, on cholinesterase activity and extracellular acetylcholine concentration in rat brain.
Isoma K; Ishikawa M; Ohta M; Ogawa Y; Hasegawa H; Kohda T; Kamei J
Jpn J Pharmacol; 2002 Feb; 88(2):206-12. PubMed ID: 11928722
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between cholinergic symptoms caused by distigmine and the activities of serum AChE and BChE].
Koga M; Miyata H; Tsuno N; Nakayama K; Ushijima S; Tanaka Y; Hiraga Y; Kobayashi N
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Jun; 17(3):143-7. PubMed ID: 9278940
[TBL] [Abstract][Full Text] [Related]
16. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
17. Long-Lasting Inhibitory Effects of Distigmine on Recombinant Human Acetylcholinesterase Activity.
Obara K; Chino D; Tanaka Y
Biol Pharm Bull; 2017; 40(10):1739-1746. PubMed ID: 28966245
[TBL] [Abstract][Full Text] [Related]
18. Mice heterozygous for AChE are more sensitive to AChE inhibitors but do not respond to BuChE inhibition.
Mohr F; Zimmermann M; Klein J
Neuropharmacology; 2013 Apr; 67():37-45. PubMed ID: 23147415
[TBL] [Abstract][Full Text] [Related]
19. The effect of HI-6 on cholinesterases and on the cholinergic system of the rat bladder.
Soukup O; Pohanka M; Tobin G; Jun D; Fusek J; Musilek K; Marek J; Kassa J; Kuca K
Neuro Endocrinol Lett; 2008 Oct; 29(5):759-62. PubMed ID: 18987577
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholinesterase and butyrylcholinesterase activity in the atria of the heart of adult albino rats.
Slavíková J; Vlk J; Hlavicková V
Physiol Bohemoslov; 1982; 31(5):407-14. PubMed ID: 6217470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
